CBUS CIBUS INC

Cibus to Report First Quarter 2024 Financial Results on May 9, 2024 and Host Conference Call

Cibus to Report First Quarter 2024 Financial Results on May 9, 2024 and Host Conference Call

SAN DIEGO, April 25, 2024 (GLOBE NEWSWIRE) -- Cibus, Inc. (Nasdaq: CBUS), a leading agricultural biotechnology company that uses proprietary gene editing technologies to develop plant traits (or specific genetic characteristics) in seeds, today announced that the company will report first quarter 2024 financial results on Thursday, May 9, 2024. Cibus’ management team will host a conference call and audio webcast at 4:30 p.m. ET on that day to discuss the financial results and other company updates.

Title: Cibus, Inc. First Quarter 2024 Results Conference Call

Event Date: Thursday, May 9, 2024        

Time: 4:30 p.m. ET        

Participant Numbers: (U.S.), (International)        

Event Link:

For interested individuals unable to join the conference call, a dial-in replay of the call will be available through Thursday, May 23, 2024 and can be accessed by dialing (U.S.), (International) and entering replay passcode: 13745788.

A live audio webcast of the call, along with accompanying slides, will be available under "News & Events” in the Investor section of the Company's website, investor.cibus.com. An archived webcast will be available on the Company's website for 90 days after the event.

About Cibus

Cibus is a leader in gene edited productivity traits that address critical productivity and sustainability challenges for farmers such as diseases and pests which the United Nations estimates cost the global economy approximately $300 billion annually. Cibus is not a seed company. It is a technology company that uses gene editing to develop and license traits to seed companies in exchange for royalties on seed sales. Cibus' focus is productivity traits for the major global crops such as canola, corn, rice, soybean, and wheat. Cibus is a technology leader in high throughput gene editing technology that enables Cibus to develop and commercialize plant traits at a fraction of the time and cost of conventional breeding. Cibus has developed a pipeline of five productivity traits including important traits for Pod Shatter Reduction, Sclerotinia resistance, and weed management. Its initial traits for Pod Shatter Reduction and weed management are developed in collaborations with leading seed companies. Its other pipeline traits including Sclerotinia resistance are in advanced greenhouse and field trial stages.

Cibus Contacts:

Investor Relations

Karen Troeber

858-450-2636

Jeff Sonnek – ICR

Media Relations

Colin Sanford



203-918-4347



EN
25/04/2024

Underlying

To request access to management, click here to engage with our
partner Phoenix-IR's CorporateAccessNetwork.com

Reports on CIBUS INC

 PRESS RELEASE

Cibus to Report First Quarter 2024 Financial Results on May 9, 2024 an...

Cibus to Report First Quarter 2024 Financial Results on May 9, 2024 and Host Conference Call SAN DIEGO, April 25, 2024 (GLOBE NEWSWIRE) -- Cibus, Inc. (Nasdaq: CBUS), a leading agricultural biotechnology company that uses proprietary gene editing technologies to develop plant traits (or specific genetic characteristics) in seeds, today announced that the company will report first quarter 2024 financial results on Thursday, May 9, 2024. Cibus’ management team will host a conference call and audio webcast at 4:30 p.m. ET on that day to discuss the financial results and other company updates...

 PRESS RELEASE

Cibus Reports Fourth Quarter Financial Results and Provides Business U...

Cibus Reports Fourth Quarter Financial Results and Provides Business Update Completed successful transfers of gene edited elite germplasm back to customers for commercialization for each of its three developed productivity traits: Pod Shatter Reduction (PSR) in Canola and Herbicide Tolerance (HT1 and HT3) in Rice Signed collaboration agreements for trait development with multiple major seed companies, including Bayer, Loveland Products (subsidiary of Nutrien Ltd), Nuseed, and Interoc Reported achievement of successful greenhouse results for two different modes of action for Sclerotinia (W...

 PRESS RELEASE

Cibus Named to Fast Company’s Annual List of the World’s Most Innovati...

Cibus Named to Fast Company’s Annual List of the World’s Most Innovative Companies of 2024 Agricultural biotechnology company joins the ranks of Nvidia, YouTube, Taco Bell, and more SAN DIEGO, March 19, 2024 (GLOBE NEWSWIRE) -- Cibus, Inc. (Nasdaq: CBUS), a leading agricultural biotechnology company that uses proprietary gene editing technologies to develop plant traits (or specific genetic characteristics) in seeds, today announced that it has been named to Fast Company’s prestigious list of the World’s Most Innovative Companies of 2024, ranking as the 2nd most innovative company in th...

 PRESS RELEASE

Cibus to Participate in the 36th Annual Roth Conference

Cibus to Participate in the 36th Annual Roth Conference SAN DIEGO, March 13, 2024 (GLOBE NEWSWIRE) -- Cibus, Inc. (Nasdaq: CBUS), a leading agricultural biotechnology company that uses proprietary gene editing technologies to develop plant traits (or specific genetic characteristics) in seeds, today announced that Rory Riggs, Co-Founder, Chief Executive Officer, and Chairman, and Peter Beetham, Co-Founder, President, and Chief Operating Officer will participate in a panel at the 36th Annual Roth Conference taking place March 17-19, 2024. Panel Title: AgTech Panel – Gene Editing in Ag and...

 PRESS RELEASE

Cibus to Report Fourth Quarter 2023 Financial Results on March 21, 202...

Cibus to Report Fourth Quarter 2023 Financial Results on March 21, 2024 and Host Conference Call SAN DIEGO, March 07, 2024 (GLOBE NEWSWIRE) -- Cibus, Inc. (Nasdaq: CBUS), a leading agricultural biotechnology company that uses proprietary gene editing technologies to develop plant traits (or specific genetic characteristics) in seeds, today announced that the company will report fourth quarter 2023 financial results on Thursday, March 21, 2024. Cibus’ management team will host a conference call and audio webcast at 4:30 p.m. ET on that day to discuss the financial results and other company...

ResearchPool Subscriptions

Get the most out of your insights

Get in touch